Not sure if this has already been posted, worth a look!Recce...

Not sure if this has already been posted, worth a look!

Recce holders remember - “Patience is bitter, but it’s fruit is sweet”

Good luck all,

Webinar Registration

Facebook Twitter LinkedIn Microsoft (Outlook)

Topic

Spark Plus Biotech Day

Description

Spark Plus is hosting its 1H 2021 Biotech Day on 25 March 2021 10AM SGT. The webinar will have Recce Pharmaceuticals (ASX: RCE), Antisense Therapeutics (ASX: ANP), and Exopharm (ASX: EX1) present for 30mins each.

Recce Pharmaceuticals (ASX: RCE):
Recce Pharmaceuticals (Recce) is pioneering the development and commercialisation of a New Class of Synthetic Anti-Infectives designed to address the urgent global health threat posed by antibiotic-resistant superbugs and emerging viral pathogens. The company's 2 core assets are RECCE 327 (to commence Phase I/II trial) - one of the first new classes of antibiotics that can continuously kill bacteria and multi-drug resistant superbugs, and RECCE 435 (pre-clinical studies) - a new broad-spectrum synthetic polymer antibiotic formulated for oral use.

Antisense Therapeutics (ASX: ANP):
Antisense Therapeutics develops antisense pharmaceuticals for large unmet markets in rare diseases. The Company is developing ATL1102 for Duchenne Muscular Dystrophy (DMD) patients and reported highly promising Phase II trial results. ATL1102 has also successfully completed a Phase II efficacy and safety trial, significantly reducing the number of brain lesions in patients with relapsing-remitting multiple sclerosis (RRMS).

Exopharm (ASX: EX1):
Exopharm is a clinical stage company at the forefront of developing transformative medicines based upon exosomes (EVs). The Company is undergoing trials for Engineered EVs (EEVs) as delivery vehicles for active cargo drugs to treat infectious diseases, neurological diseases and cancer; and Naïve EVs (NEVs) from stem cells and platelets to treat selected conditions such as osteoarthritis and chronic and acute injuries.

Time

Mar 25, 2021 10:00 AM in Singapore

• https://us02web.zoom.us/webinar/register/WN_jQ9rR08-QZu6NrWtu-9gsA